Data Foundry

Drug recalls 2023

Avicel PH-102 NF — Class III drug recall D-0545-2023

Terminated recall by DuPont Nutrition USA, Inc, reported 2023-05-03, distributed nationwide. Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Recall numberD-0545-2023
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmDuPont Nutrition USA, Inc, Newark, DE, United States
Recall initiated2023-04-13
Classified2023-04-25
Reported by FDA2023-05-03
Terminated2024-03-04
DistributedNationwide (US)
Countries outside the USAU, CA, CN, DO, ES, IE, IN, MT, MX, PE, SA, SG
Quantity320,350 kilograms
Reason classesspecification failure
Lot numbers2173755143, 2173771316, 2173773188, P220834360, P220834366, P220834383, P220834401, P220834403, P220834440, P220834460, P220834482, P220834505, P220834543, P220834545

Product

Avicel PH-102 NF, Microcrystalline Cellulose NF, Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA; Manufactured in USA; Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark.

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0545-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.